Helius stock makes gains after company responds to FDA questions about device application
January 11, 2021 at 13:53 PM EST
The company's device is designed initially to help multiple sclerosis patients with walking difficulties.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|